Document
Provisional CDC Guidelines for the Use and Safety Monitoring of Bedaquiline Fumarate (Sirturo) for the Treatment of Multidrug-Resistant Tuberculosis
Recommended citation: Provisional CDC Guidelines for the Use and Safety Monitoring of Bedaquiline Fumarate (Sirturo) for the Treatment of Multidrug-Resistant Tuberculosis. 2013. http://www.cdc.gov/mmwr/pdf/rr/rr6209.pdf.
Published:
2013
Description
The guidelines describe FDA-approved and off-label uses of bedaquiline in populations with multidrug-resistant tuberculosis that were not included in clinical trials.
Catalogue:
CDC